Viewing Study NCT00771251


Ignite Creation Date: 2025-12-24 @ 11:44 PM
Ignite Modification Date: 2026-02-21 @ 10:55 AM
Study NCT ID: NCT00771251
Status: COMPLETED
Last Update Posted: 2015-11-03
First Post: 2008-10-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Safety and Efficacy Study of Golimumab (CNTO148) in Patients With Active Rheumatoid Arthritis (RA)
Sponsor: Janssen Pharmaceutical K.K.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module